TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ZVRA

Zevra Therapeutics Inc.

Healthcare · Biotechnology

11.00$ -2.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZVRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 6.93 3.34 0.96 0.29 0.77 0.51 1.86
– 0.18 0.19 0.37 0.29 1.59 0.33 0.07 0.01 0.08 0.16 0.29
– -0.18 -0.19 -0.37 -0.29 5.34 3.01 0.89 0.29 0.69 0.35 1.57
15.49 30.25 22.44 22.49 37.26 10.48 2.22 0.34 0.57 1.12 0.91 0.22
5.88 19.29 15.35 13.95 11.16 5.84 1.99 0.29 0.44 0.70 1.19 1.36
21.38 49.54 37.79 36.43 48.43 16.31 4.42 0.63 1.52 2.09 2.23 1.65
-21.38 -49.54 -41.08 -36.43 -49.89 -10.97 -1.41 0.26 -1.23 -1.40 -1.88 -0.07
3.53 5.80 7.81 8.01 6.32 3.51 1.78 0.01 0.01 0.04 0.16 0.14
-31.82 -118.64 -18.12 -47.42 -50.50 -13.24 -3.21 -0.29 -0.78 -1.30 -1.95 1.51
-0.03 0.06 -0.02 -0.05 -0.11 -0.01 -0.01 0.00 0.00 – 0.33 0.06
-31.79 -118.69 -18.10 -47.37 -50.39 -13.23 -3.21 -0.29 -0.78 -1.30 -2.28 1.45
-21.28 -49.35 -37.59 -36.07 -48.14 -9.56 -1.36 -0.26 -0.74 -1.23 -1.65 1.72

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?